Skip to main content
Advertisement
  • Loading metrics

PLoS Medicine Issue Image | Vol. 17(9) November 2020

  • Article
  • Metrics
  • Comments
  • Media Coverage

Priorities in reducing child mortality: Azithromycin and other interventions

Despite notable reductions in child mortality since 1990, WHO estimates that about 5.2 million children aged under 5 years died worldwide in 2019, many from preventable or treatable causes. Targets set out in the Sustainable Development Goals call for further substantial reductions in under-5 mortality in all countries, with reductions in deaths from infectious diseases an ongoing priority.

In a Perspective, David Mabey, Uduak Okomo and Brian Greenwood discuss a research paper by Kieran O'Brien and colleagues in PLOS Medicine, reporting on mass azithromycin treatment for reducing child mortality among malnourished and well-nourished children in Niger, as part of the MORDOR trial.

Image Credit: Doctor 4U, Flickr (CC-BY)

thumbnail
Priorities in reducing child mortality: Azithromycin and other interventions

Despite notable reductions in child mortality since 1990, WHO estimates that about 5.2 million children aged under 5 years died worldwide in 2019, many from preventable or treatable causes. Targets set out in the Sustainable Development Goals call for further substantial reductions in under-5 mortality in all countries, with reductions in deaths from infectious diseases an ongoing priority.

In a Perspective, David Mabey, Uduak Okomo and Brian Greenwood discuss a research paper by Kieran O'Brien and colleagues in PLOS Medicine, reporting on mass azithromycin treatment for reducing child mortality among malnourished and well-nourished children in Niger, as part of the MORDOR trial.

Image Credit: Doctor 4U, Flickr (CC-BY)

https://doi.org/10.1371/image.pmed.v17.i09.g001